Lonsurf
My Prescription
Payment
Select pharmacy
$4,665.84
$30.00 due at pharmacy
$4,665.84 - $30.00 = $4,635.84
$4,635.84 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$4,665.84
Print or send this coupon to your phone
AlbertsonsPowered byAbout Lonsurf
Drug Details
Lonsurf, containing trifluridine and tipiracil, is a chemotherapy medication used to treat certain advanced cancers, specifically of the digestive system like the stomach and colon. It is typically prescribed when previous treatments have failed to control the cancer. Lonsurf works by combining two active substances that help slow down or halt the growth of cancer cells. The medication is administered orally in tablet form, usually taken twice daily on specific days within a chemotherapy cycle. While using Lonsurf, common side effects may include fatigue and stomach upset, and there is an increased risk of infections. Always consult with your healthcare provider to ensure this treatment is appropriate for your condition.
Price history for Lonsurf
20 Tablets, 15-6.14MG
Average retail price for Lonsurf
Average SaveHealth price for Lonsurf
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Lonsurf dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 15-6.14MG | 20 Tablets | $4,665.84 | $233.29 |
| 15-6.14MG | 40 Tablets | $9,323.68 | $233.09 |
| 15-6.14MG | 60 Tablets | $13,981.52 | $233.03 |
| 20-8.19MG | 20 Tablets | $6,218.46 | $310.92 |
| 20-8.19MG | 40 Tablets | $12,428.91 | $310.72 |
| 20-8.19MG | 60 Tablets | $18,639.37 | $310.66 |
Lonsurf FAQs
The life expectancy of patients taking Lonsurf (trifluridine and tipiracil) can vary based on several factors, including the stage of cancer, overall health, and response to treatment. Clinical trials have shown that Lonsurf can extend survival in patients with metastatic colorectal cancer and gastric cancer who have already undergone other treatments. On average, Lonsurf has been shown to extend median overall survival by a few months compared to placebo. However, individual outcomes can differ significantly. It is important for patients to discuss their specific prognosis with their healthcare provider.
Yes, Lonsurf is a type of chemotherapy. It is an oral medication used to treat certain types of cancer, specifically metastatic colorectal cancer and metastatic gastric cancer, when other treatments have not been effective.
The cost of Lonsurf can vary significantly based on factors such as the pharmacy, location, insurance coverage, and dosage prescribed. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may explore patient assistance programs or insurance options to help manage the cost.
Medicare may cover LONSURF under certain conditions. Coverage typically falls under Medicare Part D, which is the prescription drug plan. Beneficiaries should check with their specific Part D plan to confirm coverage details, as formularies and coverage can vary between plans. Additionally, prior authorization or specific criteria may be required for coverage. It is advisable for individuals to contact their plan provider for precise information regarding coverage and any potential out-of-pocket costs.
LONSURF is typically used for patients with metastatic colorectal cancer or metastatic gastric cancer who have already been treated with or are not candidates for other available therapies. It is often considered when other treatments have not been effective, but whether it is a "last resort" depends on the specific circumstances and treatment options available for the patient. A healthcare provider can offer guidance based on the individual's treatment history and overall health condition.